Xilio Therapeutics, Inc.XLONASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
-11.3%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 60.79% |
| 2023 | 13.66% |
| 2022 | 76.18% |
| 2021 | 87.18% |
| 2020 | -149.28% |
| 2019 | 0.00% |